Final Analysis of Early Access Protocol with AA in mCRPC Patients

ASCO 2014 - Final Analysis of a Large, Open-label Global Early Access Protocol with Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer Progressing After Chemotherapy

Cora N. Sternberg, MD
San Camillo and Forlanini Hospitals

Click HERE to view the poster from this session


Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.